AGP Picks
View all

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on September 16, 2026

Top Centrifugal Pump Manufacturer Advances Reliable Fluid Handling Solutions
Horse Peak Gelatin Launch 2026: Natural Vitality Formula For Men Read HorsePeak Gummies Supplement Facts & Ingredients Highlights
Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial
TerrAscend Strengthens Leadership Position in New Jersey with Closing of Aunt Mary’s Transaction
Joint Replacement Devices Market Size to Hit $31.09 Billion by 2030 – MarketsandMarkets™
Decoding the "Sugar Code": GAL1 Antibody-Powered Solutions for Immunity and Oncology Research
Finding Connection Through Sign Language: Braydon's Journey
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
NEXGEL Announces Date for Investor Update Call
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
BIXOLON Introduces the XM5-30 3-inch Mobile Label Printer
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
NeuroSigma Expands Payment Options for the Monarch eTNS® System
PRF Technologies’ GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.